{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:46:30Z","timestamp":1775835990751,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T00:00:00Z","timestamp":1458345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Solagran Limited supplied the Ropren."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s12035-016-9848-8","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T22:33:54Z","timestamp":1458340434000},"page":"2611-2621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antidepressant-Like Effect of Ropren\u00ae in \u03b2-Amyloid-(25\u201335) Rat Model of Alzheimer\u2019s Disease with Altered Levels of Androgens"],"prefix":"10.1007","volume":"54","author":[{"given":"Vagif","family":"Soultanov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Fedotova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Nikitina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Roschin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Ordyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-4174","authenticated-orcid":false,"given":"Lucian","family":"Hritcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,19]]},"reference":[{"issue":"4","key":"9848_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1365-2125.2011.04134.x","volume":"73","author":"S Salomone","year":"2012","unstructured":"Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F (2012) New pharmacological strategies for treatment of Alzheimer\u2019s disease: focus on disease modifying drugs. Br J Clin Pharmacol 73(4):504\u2013517. doi:\n10.1111\/j.1365-2125.2011.04134.x","journal-title":"Br J Clin Pharmacol"},{"key":"9848_CR2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","volume":"11","author":"Alzheimer\u2019s Association","year":"2015","unstructured":"Alzheimer\u2019s Association (2015) 2015 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 11:332\u2013384","journal-title":"Alzheimers Dement"},{"issue":"Suppl 1","key":"9848_CR3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.51.1_Suppl_1.S2","volume":"1","author":"J Cummings","year":"1998","unstructured":"Cummings J, Vinters H, Cole G, Khachaturian Z (1998) Alzheimer\u2019s disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 1(Suppl 1):S2\u201317","journal-title":"Neurology"},{"issue":"2","key":"9848_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat Rev Mol Cell Biol 8(2):101\u2013112","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5580","key":"9848_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s Disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356. doi:\n10.1126\/science.1072994","journal-title":"Science"},{"issue":"4","key":"9848_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","volume":"11","author":"FM LaFerla","year":"2005","unstructured":"LaFerla FM, Oddo S (2005) Alzheimer\u2019s disease: A\u03b2, tau and synaptic dysfunction. Trends Mol Med 11(4):170\u2013176. doi:\n10.1016\/j.molmed.2005.02.009","journal-title":"Trends Mol Med"},{"key":"9848_CR7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239\u2013259","journal-title":"Acta Neuropathol (Berl)"},{"key":"9848_CR8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/089198870101400111","volume":"14","author":"L Ferretti","year":"2001","unstructured":"Ferretti L, McCurry S, Logsdon R, Gibbons L, Teri L (2001) Anxiety and Alzheimer\u2019s disease. J Geriatr Psychiatry Neurol 14:52\u201358","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"9848_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00002093-200401000-00004","volume":"18","author":"TJ Hwang","year":"2004","unstructured":"Hwang TJ, Masterman DL, Ortiz F, Fairbanks LA, Cummings JL (2004) Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord 18(1):17\u201321","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"9848_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000112509","volume":"25","author":"LG Apostolova","year":"2008","unstructured":"Apostolova LG, Cummings JL (2008) Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord 25(2):115\u2013126","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9848_CR11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/WNL.46.1.130","volume":"46","author":"MS Mega","year":"1996","unstructured":"Mega MS, Cummings JL, Fiorello T, Gornbein J (1996) The spectrum of behavioral changes in Alzheimer\u2019s disease. Neurology 46:130\u2013135","journal-title":"Neurology"},{"issue":"7","key":"9848_CR12","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.cpr.2008.02.008","volume":"28","author":"PJ Seignourel","year":"2008","unstructured":"Seignourel PJ, Kunik ME, Snow L, Wilson N, Stanley M (2008) Anxiety in dementia: a critical review. Clin Psychol Rev 28(7):1071\u20131082. doi:\n10.1016\/j.cpr.2008.02.008","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"9848_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejphar.2009.10.021","volume":"626","author":"ASR Sierksma","year":"2010","unstructured":"Sierksma ASR, van den Hove DLA, Steinbusch HWM, Prickaerts J (2010) Major depression, cognitive dysfunction and Alzheimer\u2019s disease: is there a link? Eur J Pharmacol 626(1):72\u201382. doi:\n10.1016\/j.ejphar.2009.10.021","journal-title":"Eur J Pharmacol"},{"key":"9848_CR14","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/gps.1809","volume":"22","author":"R Verkaik","year":"2007","unstructured":"Verkaik R, Nuyen J, Schellevis F, Francke A (2007) The relationship between severity of Alzheimer\u2019s disease and prevalence of comorbid depressive symptoms and depression: a systematic review. Int J Geriatr Psychiatry 22:1063\u20131086","journal-title":"Int J Geriatr Psychiatry"},{"key":"9848_CR15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11920-012-0278-7","volume":"14","author":"S Weisenbach","year":"2012","unstructured":"Weisenbach S, Boore L, HC K (2012) Depression and cognitive impairment in older adults. Curr Psychiatry Rep 14:280\u2013288","journal-title":"Curr Psychiatry Rep"},{"issue":"11","key":"9848_CR16","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/jne.12080","volume":"25","author":"E Hogervorst","year":"2013","unstructured":"Hogervorst E (2013) Effects of gonadal hormones on cognitive behaviour in elderly men and women. J Neuroendocrinol 25(11):1182\u20131195. doi:\n10.1111\/jne.12080","journal-title":"J Neuroendocrinol"},{"key":"9848_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/7854_2011_136","volume-title":"Biological basis of sex differences in psychopharmacology","author":"KM Marshall","year":"2011","unstructured":"Marshall KM (2011) Introduction to the interaction between gonadal steroids and the central nervous system. In: Neill CJ, Kulkarni J (eds) Biological basis of sex differences in psychopharmacology. Springer, Berlin Heidelberg, Berlin, Heidelberg, pp 1\u201313. doi:\n10.1007\/7854_2011_136"},{"issue":"11\u201312","key":"9848_CR18","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.exger.2004.06.019","volume":"39","author":"E Hogervorst","year":"2004","unstructured":"Hogervorst E, Bandelow S, Combrinck M, Smith AD (2004) Low free testosterone is an independent risk factor for Alzheimer\u2019s disease. Exp Gerontol 39(11\u201312):1633\u20131639. doi:\n10.1016\/j.exger.2004.06.019","journal-title":"Exp Gerontol"},{"issue":"9","key":"9848_CR19","doi-asserted-by":"publisher","first-page":"906","DOI":"10.4065\/76.9.906","volume":"76","author":"RA Short","year":"2001","unstructured":"Short RA, O\u2019Brien PC, Graff-Radford NR, Bowen RL (2001) Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc 76(9):906\u2013909. doi:\n10.4065\/76.9.906","journal-title":"Mayo Clin Proc"},{"key":"9848_CR20","first-page":"39","volume":"8","author":"M Tsolaki","year":"2005","unstructured":"Tsolaki M, Grammaticos P, Karanasou C, Balaris V, Kapoukranidou D, Kalpidis I, Petsanis K, Dedousi E (2005) Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimer\u2019s dementia. Hell J Nucl Med 8:39\u201342","journal-title":"Hell J Nucl Med"},{"key":"9848_CR21","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1212\/01.WNL.0000165995.98986.F1","volume":"64","author":"MM Cherrier","year":"2005","unstructured":"Cherrier MM, Matsumoto AM, Amory JK, Asthana S, Bremner W, Peskind ER, Raskind MA, Craft S (2005) Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology 64:2063\u20132068","journal-title":"Neurology"},{"issue":"4","key":"9848_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.maturitas.2011.05.012","volume":"69","author":"J Holland","year":"2011","unstructured":"Holland J, Bandelow S, Hogervorst E (2011) Testosterone levels and cognition in elderly men: a review. Maturitas 69(4):322\u2013337. doi:\n10.1016\/j.maturitas.2011.05.012","journal-title":"Maturitas"},{"key":"9848_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archneur.63.2.nct50002","volume":"63","author":"PH Lu","year":"2006","unstructured":"Lu PH, Masterman DA, Mulnard R, Cotman C, Miller B, Yaffe K, Reback E, Porter V et al (2006) Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol 63:177\u2013185","journal-title":"Arch Neurol"},{"issue":"2","key":"9848_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.yfrne.2009.04.015","volume":"30","author":"CJ Pike","year":"2009","unstructured":"Pike CJ, Carroll JC, Rosario ER, Barron AM (2009) Protective actions of sex steroid hormones in Alzheimer\u2019s disease. Front Neuroendocrinol 30(2):239\u2013258. doi:\n10.1016\/j.yfrne.2009.04.015","journal-title":"Front Neuroendocrinol"},{"key":"9848_CR25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/tam.6.1.13.17","volume":"6","author":"RS Tan","year":"2003","unstructured":"Tan RS, Pu SJ (2003) A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer\u2019s disease. Aging Male 6:13\u201317","journal-title":"Aging Male"},{"issue":"2","key":"9848_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1385\/ENDO:29:2:233","volume":"29","author":"C Pike","year":"2006","unstructured":"Pike C, Rosario E, Nguyen T-V (2006) Androgens, aging, and Alzheimer\u2019s disease. Endocr 29(2):233\u2013241. doi:\n10.1385\/ENDO:29:2:233","journal-title":"Endocr"},{"key":"9848_CR27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1212\/WNL.62.2.188","volume":"62","author":"SD Moffat","year":"2004","unstructured":"Moffat SD, Zondrman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SN (2004) Free testosterone and risk of Alzheimer\u2019s disease in older men. Neurology 62:188\u2013193","journal-title":"Neurology"},{"issue":"4","key":"9848_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.yhbeh.2006.06.031","volume":"50","author":"M Altemus","year":"2006","unstructured":"Altemus M (2006) Sex differences in depression and anxiety disorders: Potential biological determinants. Horm Behav 50(4):534\u2013538. doi:\n10.1016\/j.yhbeh.2006.06.031","journal-title":"Horm Behav"},{"key":"9848_CR29","first-page":"4249","volume":"15","author":"CJ Blasio Di","year":"2008","unstructured":"Di Blasio CJ, Hammett J, Malcolm JB, Judge BA, Womack JH, Kincade MC, Ogles ML, Mancini JG et al (2008) Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Can J Urol 15:4249\u20134256","journal-title":"Can J Urol"},{"issue":"1","key":"9848_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.yfrne.2013.09.001","volume":"35","author":"J McHenry","year":"2014","unstructured":"McHenry J, Carrier N, Hull E, Kabbaj M (2014) Sex differences in anxiety and depression: role of testosterone. Front Neuroendocrinol 35(1):42\u201357. doi:\n10.1016\/j.yfrne.2013.09.001","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"9848_CR31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.physbeh.2009.02.022","volume":"97","author":"CA Frye","year":"2009","unstructured":"Frye CA, Walf AA (2009) Depression-like behavior of aged male and female mice is ameliorated with administration of testosterone or its metabolites. Physiol Behav 97(2):266\u2013269. doi:\n10.1016\/j.physbeh.2009.02.022","journal-title":"Physiol Behav"},{"issue":"4","key":"9848_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.yhbeh.2012.02.015","volume":"61","author":"JJ Herrera-P\u00e9rez","year":"2012","unstructured":"Herrera-P\u00e9rez JJ, Mart\u00ednez-Mota L, Chavira R, Fern\u00e1ndez-Guasti A (2012) Testosterone prevents but not reverses anhedonia in middle-aged males and lacks an effect on stress vulnerability in young adults. Horm Behav 61(4):623\u2013630. doi:\n10.1016\/j.yhbeh.2012.02.015","journal-title":"Horm Behav"},{"issue":"9","key":"9848_CR33","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.psyneuen.2011.03.004","volume":"36","author":"SR Wainwright","year":"2011","unstructured":"Wainwright SR, Lieblich SE, Galea LAM (2011) Hypogonadism predisposes males to the development of behavioural and neuroplastic depressive phenotypes. Psychoneuroendocrinology 36(9):1327\u20131341. doi:\n10.1016\/j.psyneuen.2011.03.004","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"9848_CR34","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.yhbeh.2012.03.001","volume":"61","author":"N Carrier","year":"2012","unstructured":"Carrier N, Kabbaj M (2012) Testosterone and imipramine have antidepressant effects in socially isolated male but not female rats. Horm Behav 61(5):678\u2013685. doi:\n10.1016\/j.yhbeh.2012.03.001","journal-title":"Horm Behav"},{"issue":"5","key":"9848_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00120-009-1954-z","volume":"48","author":"L Rinnab","year":"2009","unstructured":"Rinnab L, Gust K, Hautmann RE, K\u00fcfer R (2009) Testosterone replacement therapy and prostate cancer. The current position 67 years after the Huggins myth. Urologe A 48(5):516\u2013522. doi:\n10.1007\/s00120-009-1954-z","journal-title":"Urologe A"},{"issue":"3","key":"9848_CR36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.tcm.2014.10.014","volume":"25","author":"JP Walsh","year":"2015","unstructured":"Walsh JP, Kitchens AC (2015) Testosterone therapy and cardiovascular risk. Trends Cardiovasc Med 25(3):250\u2013257. doi:\n10.1016\/j.tcm.2014.10.014","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"9848_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/WAD.0b013e318258cd63","volume":"27","author":"J Butchart","year":"2013","unstructured":"Butchart J, Birch B, Bassily R, Wolfe L, Holmes C (2013) Male sex hormones and systemic inflammation in Alzheimer disease. Alzheimer Dis Assoc Disord 27(2):153\u2013156. doi:\n10.1097\/WAD.0b013e318258cd63","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"9848_CR38","doi-asserted-by":"publisher","first-page":"386527","DOI":"10.1155\/2012\/386527","volume":"2012","author":"S Davinelli","year":"2012","unstructured":"Davinelli S, Sapere N, Zella D, Bracale R, Intrieri M, Scapagnini G (2012) Pleiotropic protective effects of phytochemicals in Alzheimer\u2019s disease. Oxid Med Cell Longev 2012:386527. doi:\n10.1155\/2012\/386527","journal-title":"Oxid Med Cell Longev"},{"key":"9848_CR39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/138161212798919002","volume":"18","author":"HG Kim","year":"2012","unstructured":"Kim HG, Oh MS (2012) Herbal medicines for the prevention and treatment of Alzheimer\u2019s disease. Curr Pharm Des 18:57\u201375","journal-title":"Curr Pharm Des"},{"key":"9848_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.physbeh.2016.01.035","volume":"157","author":"J Fedotova","year":"2016","unstructured":"Fedotova J, Soultanov V, Nikitina T, Roschin V, Ordyan N, Hritcu L (2016) Cognitive-enhancing activities of the polyprenol preparation Ropren\u00ae in gonadectomized \u03b2-amyloid (25\u201335) rat model of Alzheimer\u2019s disease. Physiol Behav 157:55\u201362. doi:\n10.1016\/j.physbeh.2016.01.035","journal-title":"Physiol Behav"},{"key":"9848_CR41","volume-title":"Harvesting and utilization of tree foliage","author":"AC Blogger","year":"1989","unstructured":"Blogger AC, Rubens JP, Roshchin VI (1989) Harvesting and utilization of tree foliage. IUFRO Project Group, Riga"},{"key":"9848_CR42","first-page":"151","volume":"32","author":"VN Vasiliev","year":"1996","unstructured":"Vasiliev VN, Roschin VI, Felece S (1996) Extracting compounds of Picea abies (L.) Karst. Rast Resursy 32:151\u2013180","journal-title":"Rast Resursy"},{"issue":"6","key":"9848_CR43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1023\/B:BGEN.0000006555.87407.04","volume":"4","author":"R Bizzarri","year":"2003","unstructured":"Bizzarri R, Cerbai B, Signori F, Solaro R, Bergamini E, Tamburini I, Chiellini E (2003) New perspectives for (S)-dolichol and (S)-nordolichol synthesis and biological functions. Biogerontology 4(6):353\u2013363. doi:\n10.1023\/B:BGEN.0000006555.87407.04","journal-title":"Biogerontology"},{"issue":"4","key":"9848_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.plipres.2005.05.002","volume":"44","author":"E Swiezewska","year":"2005","unstructured":"Swiezewska E, Danikiewicz W (2005) Polyisoprenoids: Structure, biosynthesis and function. Prog Lipid Res 44(4):235\u2013258. doi:\n10.1016\/j.plipres.2005.05.002","journal-title":"Prog Lipid Res"},{"issue":"2\u20133","key":"9848_CR45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.brainresbull.2011.11.014","volume":"87","author":"D-Y Choi","year":"2012","unstructured":"Choi D-Y, Lee Y-J, Hong JT, Lee H-J (2012) Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer\u2019s disease. Brain Res Bull 87(2\u20133):144\u2013153. doi:\n10.1016\/j.brainresbull.2011.11.014","journal-title":"Brain Res Bull"},{"key":"9848_CR46","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/jnr.20845","volume":"83","author":"X Cui","year":"2006","unstructured":"Cui X, Zuo P, Zhang Q, Li X, Hu Y, Long J, Packer L, Liu J (2006) Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J Neurosci Res 83:1584\u20131590","journal-title":"J Neurosci Res"},{"issue":"5","key":"9848_CR47","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.freeradbiomed.2010.11.026","volume":"51","author":"M Dumont","year":"2011","unstructured":"Dumont M, Beal MF (2011) Neuroprotective strategies involving ROS in Alzheimer\u2019s disease. Free Radic Biol Med 51(5):1014\u20131026. doi:\n10.1016\/j.freeradbiomed.2010.11.026","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"9848_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00005-013-0253-y","volume":"62","author":"A Pronin","year":"2014","unstructured":"Pronin A, Danilov L, Narovlyansky A, Sanin A (2014) Plant polyisoprenoids and control of cholesterol level. Arch Immunol Ther Exp (Warsz) 62(1):31\u201339. doi:\n10.1007\/s00005-013-0253-y","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"9848_CR49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/tcr.20137","volume":"8","author":"K Skorupinska-Tudek","year":"2008","unstructured":"Skorupinska-Tudek K, Wojcik J, Swiezewska E (2008) Polyisoprenoid alcohols\u2014recent results of structural studies. Chem Rec 8:33\u201345","journal-title":"Chem Rec"},{"key":"9848_CR50","first-page":"2","volume":"73","author":"I Fedotova","year":"2010","unstructured":"Fedotova I, Sultanov V, Kuznetsova N, Roshchin V, Nikitina T (2010) Effect of new polyprenol drug ropren on anxiety-depressive-like behavior in rats with experimental model Alzheimer disease. Eksp Klin Farmakol 73:2\u20135","journal-title":"Eksp Klin Farmakol"},{"issue":"5","key":"9848_CR51","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.phymed.2011.09.073","volume":"19","author":"J Fedotova","year":"2012","unstructured":"Fedotova J, Soultanov V, Nikitina T, Roschin V, Ordayn N (2012) Ropren\u00ae is a polyprenol preparation from coniferous plants that ameliorates cognitive deficiency in a rat model of beta-amyloid peptide-(25\u201335)-induced amnesia. Phytomedicine 19(5):451\u2013456. doi:\n10.1016\/j.phymed.2011.09.073","journal-title":"Phytomedicine"},{"issue":"1","key":"9848_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neuroscience.2006.11.060","volume":"145","author":"B Klementiev","year":"2007","unstructured":"Klementiev B, Novikova T, Novitskaya V, Walmod PS, Dmytriyeva O, Pakkenberg B, Berezin V, Bock E (2007) A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by A\u03b225-35. Neuroscience 145(1):209\u2013224. doi:\n10.1016\/j.neuroscience.2006.11.060","journal-title":"Neuroscience"},{"key":"9848_CR53","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"2007","unstructured":"Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. Academic Press, London","edition":"6"},{"key":"9848_CR54","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"R Porsolt","year":"1978","unstructured":"Porsolt R, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379\u2013391","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"9848_CR55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0924-977X(14)70580-2","volume":"24","author":"J Fedotova","year":"2014","unstructured":"Fedotova J (2014) Blockade of D1 dopaminergic receptors corrects depression-like behaviour in gonadectomized rats treated with a low dose of testosterone. Eur Neuropsychopharmacol 24(2):363","journal-title":"Eur Neuropsychopharmacol"},{"key":"9848_CR56","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"M Detke","year":"1995","unstructured":"Detke M, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66\u201372","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"9848_CR57","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.arr.2005.03.003","volume":"4","author":"DF Swaab","year":"2005","unstructured":"Swaab DF, Bao A-M, Lucassen PJ (2005) The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 4(2):141\u2013194. doi:\n10.1016\/j.arr.2005.03.003","journal-title":"Ageing Res Rev"},{"key":"9848_CR58","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1017\/S0033291702005998","volume":"32","author":"S Watson","year":"2002","unstructured":"Watson S, Gallagher P, Del-Estal D, Hearn A, Ferrier IN, Young AH (2002) Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol Med 32:1021\u20131028","journal-title":"Psychol Med"},{"key":"9848_CR59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0889-8529(01)00002-0","volume":"31","author":"EA Young","year":"2002","unstructured":"Young EA, Korszun A (2002) The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinol Metab Clin North Am 31:63\u201378","journal-title":"Endocrinol Metab Clin North Am"},{"key":"9848_CR60","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0361-9230(94)90117-1","volume":"35","author":"E Bingaman","year":"1994","unstructured":"Bingaman E, Baeckman L, Yracheta J, Handa R, Gray T (1994) Localization of androgen receptor within peptidergic neurons of the rat forebrain. Brain Res Bull 35:379\u2013382","journal-title":"Brain Res Bull"},{"issue":"4","key":"9848_CR61","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1006\/hbeh.1994.1044","volume":"28","author":"RJ Handa","year":"1994","unstructured":"Handa RJ, Burgess LH, Kerr JE, O\u2019Keefe JA (1994) Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm Behav 28(4):464\u2013476. doi:\n10.1006\/hbeh.1994.1044","journal-title":"Horm Behav"},{"issue":"4","key":"9848_CR62","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2826.2009.01840.x","volume":"21","author":"RJ Handa","year":"2009","unstructured":"Handa RJ, Weiser MJ, Zuloaga DG (2009) A role for the androgen metabolite, 5\u03b1-androstane-3\u03b2,17\u03b2-diol, in modulating oestrogen receptor \u03b2-mediated regulation of hormonal stress reactivity. J Neuroendocrinol 21(4):351\u2013358. doi:\n10.1111\/j.1365-2826.2009.01840.x","journal-title":"J Neuroendocrinol"},{"issue":"7","key":"9848_CR63","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1210\/en.2003-0064","volume":"144","author":"V Viau","year":"2003","unstructured":"Viau V, Lee P, Sampson J, Wu J (2003) A testicular influence on restraint-induced activation of medial parvocellular neurons in the paraventricular nucleus in the male rat. Endocrinology 144(7):3067\u20133075. doi:\n10.1210\/en.2003-0064","journal-title":"Endocrinology"},{"key":"9848_CR64","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2826.2002.00798.x","volume":"14","author":"V Viau","year":"2002","unstructured":"Viau V (2002) Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes. J Neuroendocrinology 14:506\u2013513","journal-title":"J Neuroendocrinology"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-9848-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9848-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9848-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9848-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:48:15Z","timestamp":1559429295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-9848-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,19]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["9848"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-9848-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,19]]}}}